TrialJCI insight2025

A TMPRSS6-inhibiting mAb improves disease in a β-thalassemia mouse model and reduces iron in healthy humans.

Heinrich E Lob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.